Microbot Medical reported over 100% growth in revenue and new customers for Q2 2026, announcing plans to expand its U.S. sales territories and enter international markets. The period also saw significant M&A activity, with BiomX signing a letter of intent to acquire an Israeli security infrastructure firm, and Stereotaxis completing its acquisition of robotic innovator Robocath. Additionally, IKS Health finalized its acquisition of TruBridge, a provider of EHR and revenue cycle management solutions.
